Cargando…
Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
OBJECTIVE: To assess the association between antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS). RESEARCH DESIGN AND METHODS: DPP/DPPOS participants were assessed for diabetes every 6 months...
Autores principales: | Rubin, Richard R., Ma, Yong, Peyrot, Mark, Marrero, David G., Price, David W., Barrett-Connor, Elizabeth, Knowler, William C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992187/ https://www.ncbi.nlm.nih.gov/pubmed/20805256 http://dx.doi.org/10.2337/dc10-1033 |
Ejemplares similares
-
Depression as a Predictor of Weight Regain Among Successful Weight Losers in the Diabetes Prevention Program
por: Price, David W., et al.
Publicado: (2013) -
Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2008) -
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021) -
Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2009) -
The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program
por: Florez, Jose C., et al.
Publicado: (2012)